Responses

PDF

Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Satisfaction of Dupuytren's disease with treatment with collagenase
    • Francisco Javier Carrera-Hueso, Pharmacist Pharmacy Servicie. Hospital Dr Moliner. Valencia (Spain)
    • Other Contributors:
      • Rafael Sanjuan-Cerveró, MD Traumatologist.
      • Pedro Vaue-Ferreiro, MD Ophtalmologist

    Dear Editor,
    Recently published in your journal, Lauritzson & Atroshi1 used a dichotomic question for the assessment of patient satisfaction in Dupuytren Disease (DD) treated with collagenase Clostridium hystolyticum (CCH). This satisfaction was correlated with the 11-item disabilities of the arm, shoulder and hand (QuickDASH) scale. Follow up was made initially at 5 weeks and at 2 years, answering the patients to both questionnaires.
    This way of proceeding is adequate. To contemplate the level of satisfaction of patients with their clinical results achieved or about the therapeutic process applied must be done2. However the way to measure satisfaction is not the best. Satisfaction is a multidimensional concept and it is not possible to valuate only with a dichotomic question. The expectation that the patient has about the care, staff or hospital in which he or she has been treated is a fundamental element to know this satisfaction. It has long been considered that satisfaction has between three to ten dimensions, mainly: cognitive (quantity, type and quality of information given by the doctor); affective (interest and understanding that shows); and behavioral (on the abilities and clinical competences of the physician).
    Measurement satisfaction in this article has important bias of selection and information. There may be both a Hawthorne bias (by questions asked directly by a therapist) as well as a recall bias (by the time elapsed and the advanced a...

    Show More
    Conflict of Interest:
    None declared.